Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    15765399 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
Condition: HIV-1 and Hepatitis C Co-Infection
Interventions: Drug: pioglitazone;   Drug: peginterferon;   Drug: ribavirin
2 Terminated EXtended Therapy in Hepatitis C Genotype 3 Infected Patients
Condition: Chronic Hepatitis C
Intervention: Drug: Peginterferon alfa-2b (Pegetron) plus ribavirin (Rebetol)
3 Suspended Retreatment of Chronic Hepatitis C Non-Responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone
Condition: Chronic Hepatitis C
Interventions: Drug: Pioglitazone;   Drug: Increase response to interferon alpha plus ribavirin by increasing insulin sensitivity
4 Completed NIDDM and IR in Combination Therapy for CHC
Conditions: Chronic Hepatitis C;   Insulin Resistance
Intervention: Drug: pegylated interferon alpha and ribavirin
5 Unknown  Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance
Conditions: Chronic Hepatitis C;   Insulin Resistance
Intervention: Drug: metformin

Indicates status has not been verified in more than two years